scholarly journals Human Mesenchymal Stem Cells Promote Survival of T Cells in a Quiescent State

Stem Cells ◽  
2007 ◽  
Vol 25 (7) ◽  
pp. 1753-1760 ◽  
Author(s):  
Federica Benvenuto ◽  
Stefania Ferrari ◽  
Ezio Gerdoni ◽  
Francesca Gualandi ◽  
Francesco Frassoni ◽  
...  
2020 ◽  
Vol 2020 ◽  
pp. 1-10
Author(s):  
Hong Kyung Lee ◽  
Eun Young Kim ◽  
Hyung Sook Kim ◽  
Eun Jae Park ◽  
Hye Jin Lee ◽  
...  

Systemic lupus erythematosus (SLE) is an autoimmune disease, which is characterized by hyperactivation of T and B cells. Human mesenchymal stem cells (hMSCs) ameliorate the progression of SLE in preclinical studies using lupus-prone MRL.Faslpr mice. However, whether hMSCs inhibit the functions of xenogeneic mouse T and B cells is not clear. To address this issue, we examined the in vitro effects of hMSCs on T and B cells isolated from MRL.Faslpr mice. Naïve hMSCs inhibited the functions of T cells but not B cells. hMSCs preconditioned with IFN-γ (i) inhibited the proliferation of and IgM production by B cells, (ii) attracted B cells for cell–cell interactions in a CXCL10-dependent manner, and (iii) inhibited B cells by producing indoleamine 2,3-dioxygenase. In summary, our data demonstrate that hMSCs exert therapeutic activity in mice in three steps: first, naïve hMSCs inhibit the functions of T cells, hMSCs are then activated by IFN-γ, and finally, they inhibit B cells.


2011 ◽  
Vol 20 (10) ◽  
pp. 1547-1559 ◽  
Author(s):  
Meindert J. Crop ◽  
Sander S. Korevaar ◽  
Ronella De Kuiper ◽  
Jan N. M. Ijzermans ◽  
Nicole M. Van Besouw ◽  
...  

Blood ◽  
2005 ◽  
Vol 105 (5) ◽  
pp. 2214-2219 ◽  
Author(s):  
Shaul Beyth ◽  
Zipora Borovsky ◽  
Dror Mevorach ◽  
Meir Liebergall ◽  
Zulma Gazit ◽  
...  

AbstractInfusion of either embryonic or mesenchymal stem cells prolongs the survival of organ transplants derived from stem cell donors and prevents graft-versus-host-disease (GVHD). An in-depth mechanistic understanding of this tolerization phenomenon could lead to novel cell-based therapies for transplantation. Here we demonstrate that while human mesenchymal stem cells (hMSCs) can promote superantigen-induced activation of purified T cells, addition of antigen-presenting cells (APCs; either monocytes or dendritic cells) to the cultures inhibits the T-cell responses. This contact- and dose-dependent inhibition is accompanied by secretion of large quantities of interleukin (IL)–10 and aberrant APC maturation, which can be partially overridden by the addition of factors that promote APC maturation (ie, lipopolysaccharide [LPS] or anti-CD40 monoclonal antibody [mAb]). Thus, our data support an immunoregulatory mechanism wherein hMSCs inhibit T cells indirectly by contact-dependent induction of regulatory APCs with T-cell–suppressive properties. Our data may reveal a physiologic phenomenon whereby the development of a distinct APC population is regulated by the tissue's cellular microenvironment.


2012 ◽  
Vol 125 (19) ◽  
pp. 4640-4650 ◽  
Author(s):  
I. Hof-Nahor ◽  
L. Leshansky ◽  
S. Shivtiel ◽  
L. Eldor ◽  
D. Aberdam ◽  
...  

Stem Cells ◽  
2009 ◽  
Vol 27 (3) ◽  
pp. 693-702 ◽  
Author(s):  
Ignazia Prigione ◽  
Federica Benvenuto ◽  
Paola Bocca ◽  
Luca Battistini ◽  
Antonio Uccelli ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document